Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

341

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Human RightsNews

Togolese Protesters Tear-Gassed in Their Homes as Uprising Demands President’s Resignation

Togolese youths have taken to the streets in a three-day demonstration, demanding...

FinanceNews

DR Congo, Rwanda to Sign US-Mediated Peace Deal  

The Democratic Republic of Congo (DRC) and Rwanda are set to sign...

NewsSecurity

Niger Counter-Terrorism: Four Suspects Captured in Tanda, Including Alleged Militant Leader

A high-risk counter-terrorism operation conducted on June 25 in the village of...

FinanceNews

Missing ₦210tn: Nigerian Senate Rejects NNPCL’s Retreat Excuse, Gives 10-Day Ultimatum to Appear Before Probe Panel

The Nigerian National Petroleum Company Limited (NNPCL) on Thursday failed to appear...